Table 1.
Characteristic | Value | |
---|---|---|
Male sex | 32 (60) | |
Age at first symptom onset, years | 0.95 ± 1.07 | |
Age at diagnosis, years | 3.12 ± 2.49 | |
Lead time to diagnosis, years | 2.17 ± 2.11 | |
First symptom | Seizure | 26 (49) |
Delayed development | 22 (42) | |
Visual disturbance | 1 (2) | |
Ataxia | 1 (2) | |
Dystonia | 1 (2) | |
Nystagmus | 1 (2) | |
Hearing impairment | 1 (2) | |
Lactic acidosis severity | Normal | 23 (43) |
Mild | 22 (42) | |
Moderate | 7 (13) | |
Severe | 1 (2) | |
Myopathies by pathologic features | Normal | 10 (19) |
One pathology | 23 (43) | |
Two pathologies | 20 (38) | |
Biochemical enzyme assay | MRC I complex deficiency | 48 (92) |
MRC II complex deficiency | 1 (2) | |
MRC IV complex deficiency | 3 (6) | |
Syndromic diagnosis | Leigh syndrome | 11 (21) |
MELAS | 2 (4) | |
Non-specific MD | 40 (76) |
Data given as total number (percentage) or mean ± SD.
MD, mitochondrial disease; MRC, mitochondrial respiratory chain; MELAS, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.